Ladenburg Thalmann Financial Services’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
SMG
FAIM
AWCI
Ladenburg Thalmann Financial Services's BBP Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Virtus Biotech ETF (BBP) stake by 12% in Q4 2019, selling an estimated $6.83K and leaving 1,301 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3431.
Ladenburg Thalmann Financial Services first reported a position in BBP in Q1 2015 and has held it in 20 quarters since. The position peaked at $204K in Q3 2018. 17 funds tracked by Wall St. Rank hold BBP as of Q4 2019.
- Ladenburg Thalmann Financial Services held 1,301 shares of Virtus Biotech ETF worth $57K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 170 Virtus Biotech ETF shares in Q4 2019, an estimated $6.83K.
- Virtus Biotech ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3431 holding.
- Ladenburg Thalmann Financial Services first reported a position in Virtus Biotech ETF in Q1 2015 and has held it in 20 quarters since.
- Ladenburg Thalmann Financial Services's Virtus Biotech ETF position peaked at $204K in Q3 2018.
- 17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.